- Home
- IAS vs CERT Comparison
IAS vs CERT Comparison
Compare IAS & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IAS
- CERT
- Stock Information
- Founded
- IAS 2009
- CERT 2008
- Country
- IAS United States
- CERT United States
- Employees
- IAS N/A
- CERT N/A
- Industry
- IAS Computer Software: Programming Data Processing
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- IAS Technology
- CERT Technology
- Exchange
- IAS Nasdaq
- CERT Nasdaq
- Market Cap
- IAS 1.8B
- CERT 1.9B
- IPO Year
- IAS 2021
- CERT 2020
- Fundamental
- Price
- IAS $10.15
- CERT $12.61
- Analyst Decision
- IAS Buy
- CERT Buy
- Analyst Count
- IAS 11
- CERT 7
- Target Price
- IAS $14.80
- CERT $15.92
- AVG Volume (30 Days)
- IAS 768.9K
- CERT 1.0M
- Earning Date
- IAS 02-25-2025
- CERT 02-27-2025
- Dividend Yield
- IAS N/A
- CERT N/A
- EPS Growth
- IAS 258.32
- CERT N/A
- EPS
- IAS 0.20
- CERT N/A
- Revenue
- IAS $511,358,000.00
- CERT $372,797,000.00
- Revenue This Year
- IAS $11.97
- CERT $10.20
- Revenue Next Year
- IAS $11.96
- CERT $10.01
- P/E Ratio
- IAS $51.86
- CERT N/A
- Revenue Growth
- IAS 11.77
- CERT 5.62
- 52 Week Low
- IAS $7.98
- CERT $9.41
- 52 Week High
- IAS $17.53
- CERT $19.87
- Technical
- Relative Strength Index (RSI)
- IAS 46.51
- CERT 66.73
- Support Level
- IAS $9.86
- CERT $10.46
- Resistance Level
- IAS $10.15
- CERT $12.21
- Average True Range (ATR)
- IAS 0.32
- CERT 0.60
- MACD
- IAS 0.02
- CERT 0.15
- Stochastic Oscillator
- IAS 43.72
- CERT 97.47
About IAS Integral Ad Science Holding Corp.
Integral Ad Science Holding Corp is a digital advertising verification company. The cloud-based technology platform of the company delivers independent measurement and verification of digital advertising across all devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video. Geographically, the company derives a majority of its revenue from the Americas region.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.